CN1686326A - zedoary turmeric oil submicron emulsion and preparation method thereof - Google Patents
zedoary turmeric oil submicron emulsion and preparation method thereof Download PDFInfo
- Publication number
- CN1686326A CN1686326A CN 200510046368 CN200510046368A CN1686326A CN 1686326 A CN1686326 A CN 1686326A CN 200510046368 CN200510046368 CN 200510046368 CN 200510046368 A CN200510046368 A CN 200510046368A CN 1686326 A CN1686326 A CN 1686326A
- Authority
- CN
- China
- Prior art keywords
- oil
- emulsion
- injection
- lecithin
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 62
- 240000009138 Curcuma zedoaria Species 0.000 title claims abstract description 52
- 235000003405 Curcuma zedoaria Nutrition 0.000 title claims abstract description 45
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 title claims abstract description 45
- 235000019509 white turmeric Nutrition 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 239000010681 turmeric oil Substances 0.000 title claims abstract description 9
- 238000004945 emulsification Methods 0.000 title description 4
- 239000003921 oil Substances 0.000 claims abstract description 50
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 22
- 239000000787 lecithin Substances 0.000 claims abstract description 22
- 235000010445 lecithin Nutrition 0.000 claims abstract description 22
- 229940067606 lecithin Drugs 0.000 claims abstract description 22
- 239000008215 water for injection Substances 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 19
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 210000000481 breast Anatomy 0.000 claims description 11
- 210000003022 colostrum Anatomy 0.000 claims description 11
- 235000021277 colostrum Nutrition 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 9
- 238000000265 homogenisation Methods 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 5
- 229940083466 soybean lecithin Drugs 0.000 claims description 5
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 235000020603 homogenised milk Nutrition 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 abstract description 43
- 238000002347 injection Methods 0.000 abstract description 28
- 239000007924 injection Substances 0.000 abstract description 28
- 239000003814 drug Substances 0.000 abstract description 22
- 235000012424 soybean oil Nutrition 0.000 abstract description 17
- 239000003549 soybean oil Substances 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 16
- 235000011187 glycerol Nutrition 0.000 abstract description 13
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 8
- 230000000840 anti-viral effect Effects 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 5
- 206010018910 Haemolysis Diseases 0.000 abstract description 4
- 230000008588 hemolysis Effects 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 3
- 230000001093 anti-cancer Effects 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 3
- 231100000869 headache Toxicity 0.000 abstract description 3
- 230000007794 irritation Effects 0.000 abstract description 3
- 238000007086 side reaction Methods 0.000 abstract description 3
- 230000008685 targeting Effects 0.000 abstract description 3
- 239000004005 microsphere Substances 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 abstract description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 abstract 1
- 108010082126 Alanine transaminase Proteins 0.000 abstract 1
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 230000036783 anaphylactic response Effects 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 description 35
- 235000014375 Curcuma Nutrition 0.000 description 29
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 29
- 229940090044 injection Drugs 0.000 description 26
- 239000000243 solution Substances 0.000 description 18
- 239000002245 particle Substances 0.000 description 14
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 13
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 13
- 235000013336 milk Nutrition 0.000 description 13
- 239000008267 milk Substances 0.000 description 13
- 210000004080 milk Anatomy 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000004530 micro-emulsion Substances 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- 230000004936 stimulating effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 7
- 229920000053 polysorbate 80 Polymers 0.000 description 7
- 235000003392 Curcuma domestica Nutrition 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 235000003373 curcuma longa Nutrition 0.000 description 6
- 239000002960 lipid emulsion Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 235000013976 turmeric Nutrition 0.000 description 6
- 239000007789 gas Substances 0.000 description 5
- 210000000440 neutrophil Anatomy 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 210000004276 hyalin Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000003182 parenteral nutrition solution Substances 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000963421 Curcuma kwangsiensis Species 0.000 description 1
- 235000003397 Curcuma kwangsiensis Nutrition 0.000 description 1
- 240000005629 Curcuma phaeocaulis Species 0.000 description 1
- 235000003391 Curcuma phaeocaulis Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 235000003394 Curcuma wenyujin Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010022079 Injection site irritation Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention relates to a zedoary turmeric oil submicron emulsion without soybean oil and a preparation method thereof, belonging to the technical field of medicines, having antiviral and anticancer effects and being used for injection or oral administration. The composition comprises the following raw materials in percentage by weight: zedoary turmeric oil, lecithin, glycerol and water for injection are 1-5: 0.5-3: 70-90; stirring with high-speed homogenizer or ultrasonic oscillating to form primary emulsion, and making into zedoary turmeric oil submicron emulsion with high-pressure homogenizer. The preparation is an oil-in-water type submicron emulsion, has high stability, wraps main drug zedoary turmeric oil in oil-in-water microsphere oil phase, and the oil phase is completely composed of drugs, thereby relieving injection irritation reaction, hemolysis and anaphylaxis side reaction, simultaneously having no side effect of fever, headache and glutamic-pyruvic transaminase increase, having targeting effect, and improving drug effect.
Description
Affiliated technical field
The present invention relates to a kind of medicine curcuma zedoary oil submicro emulsion and preparation method, relate in particular to a kind of have antiviral, antitumaous effect, can be used for injection or oral, do not contain the curcuma zedoary oil submicro emulsion and the preparation method of soybean oil.
Background technology
Oleum Curcumae is the plant volatile oil from zingiberaceous plant Rhizoma Curcumae Curcuma phaeocaulis Valeton. or Guangxi zedoary Curcuma kwangsiensis S.G.Lee et C.F. or RADIX CURCUMAE Curcuma Wenyujin Y.H.chenet C.Ling extraction, its quality standard should meet the Chinese Pharmacopoeia regulation, that Oleum Curcumae has is anticancer, antiviral, pain relieving, effect such as antipruritic, with the injection that Oleum Curcumae is made, suppository, ointment are widely used in clinically.
Contain a large amount of cosolvent tween 80s in the Oleum Curcumae injection of listing and the Zedoary turmeric oil glucose injection prescription at present, produce a lot of side effect clinically, as haemolysis, allergy etc., bring many unsafe factors to clinical practice, so that therefore the issue alerting Oleum Curcumae injection untoward reaction of untoward reaction monitoring center of State Food and Drug Administration has limited the application of Oleum Curcumae.Though reporting in the past, No. 200410022045.5, Chinese patent and present inventor do not contain tween 80 in the Chinese patent 200410100424.1, but with soybean oil as carrier, and may bring side effect thus, may produce heating, shiver with cold, cardiopalmus, rapid breathing, headache side reaction, long-term input causes untoward reaction such as Glutamate pyruvate transaminase rises easily.The curcuma zedoary oil fat that contains soybean oil free fatty and lipid peroxide content when long-term the placement can raise, and cause the shelf-life to shorten, and side effect increases.In order to prevent lipid oxidation, need usually to add antioxidant, increased safe uncertainty.Chinese patent discloses Oleum Curcumae injection and preparation method No. 03146102.6, in this patent, still for using the surfactant tween 80, Chinese patent adopts for No. 02109680.5 HP-β-CD to carry out enclose to the technical scheme that is adopted, avoid the use tween 80, but must make injectable powder.Shenyang Pharmacy College's journal, o. 11ths in 1973 were once reported the preparation method of " Oleum Curcumae emulsion injection ", but the document also uses tween 80 to prepare Emulsion as the emulsifying agent method.All adopting soybean oil in No. 200410022045.5, the Chinese patent and 200410100424.1 is that preparing carriers becomes lipomul, need to use a large amount of soybean oils, all do not relate to curcuma zedoary oil submicro emulsion that does not contain tween 80 and soybean oil and preparation method thereof in the present disclosed document.
Summary of the invention
The present invention is directed to the problem of above-mentioned existence, a kind of curcuma zedoary oil submicro emulsion and preparation method are provided, this kind preparation is a kind of oil-in-water emulsion, with the principal agent Oleum Curcumae is oil phase, under the effect of phospholipid, form the oil-in-water type nanoparticle, the breast grain all is made up of medicine, rate of release is fast, drug effect is obvious, has alleviated the injection site irritation reaction simultaneously, and haemolysis, allergic side reactions, have targeting, it does not contain tween 80 and soybean oil and other antioxidants.
The oil phase of common submicronized emulsion mainly is made up of middle long-chain fatty acid, as vegetable oil such as soybean oil, Oleum Sesami, and Oleum Curcumae is a volatile oil, is mainly become to be grouped into by terpenes, do not contain fatty acid composition in the soybean oil, do not exist because free fatty raises and cause the downgrade phenomenon.But this terpenes composition can mix with arbitrary proportion under the emulsifying agent effect with water unlike soybean oil, when the Oleum Curcumae oil-water ratio surpasses 5%, will influence Emulsion and form, and may cause the flocculation of emulsifier lecithin, therefore, generally is controlled within 5%.When preparing general colostrum, heating helps Emulsion to form, but preparation Oleum Curcumae breast of the present invention should at room temperature carry out, because high temperature also easily causes the lecithin flocculation.Curcuma zedoary oil submicro emulsion by the inventive method preparation is compared with the fat emulsion of oil of zedoary turmeric that contains soybean oil, has littler breast grain particle diameter.
Curcuma zedoary oil submicro emulsion of the present invention by the following raw materials in parts by weight number than forming:
Oleum Curcumae: lecithin: glycerol: water for injection=1～5: 0.5～3: 0.5～3: 70～90.
Curcuma zedoary oil submicro emulsion of the present invention is made up of by the preferred value weight ratio following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=1～2: 1～1.5: 2～2.5: 85～95;
Described lecithin is egg yolk lecithin or soybean lecithin
A kind of preparation method of described curcuma zedoary oil submicro emulsion is:
Selection meets the Oleum Curcumae of Chinese Pharmacopoeia regulation, gets Oleum Curcumae by above-mentioned weight ratio, is oil phase; By the refining lecithin of above-mentioned weight ratio weighing, add in the water for injection, add glycerol again, be heated to 50～70 ℃, homogenizing disperseed 2～5 minutes in the high-speed homogenization machine, was cooled to room temperature, was water; Add oil phase to aqueous phase, high-speed homogenization 2～5 minutes forms colostrum; Colostrum is joined in the equal machine of high pressure breast, under 20～100Mpa pressure, logical N
2Protection through 3-6 circulation, forms the Emulsion of homogeneous; emit homogenized milk, adopt microporous filter membrane equipment, cross 0.45 μ m filter membrane; packing after 0.22 μ m filter membrane degerming perhaps adopts pressure sterilizing to sterilize after the packing, the pressure sterilizing condition is 121 ℃, 15 minutes or 115 ℃, 30 minutes.
The method of described sterilization also can adopt the method for microwave sterilizating, after promptly curcuma zedoary oil submicro emulsion filters, fills N
2, fill, under the 2450MHZ frequency, power 1KW sterilized 30 seconds, promptly.
The described method for preparing colostrum can adopt the supersonic oscillations method.
The formulation characteristics that the present invention obtains is the oil-in-water emulsion that contains the Oleum Curcumae all the components, and the oil-in-water microspherulite diameter below 300nm, contains curcumenol 1-10mg/ml usually.
The content assaying method of curcuma zedoary oil submicro emulsion of the present invention mainly adopts gas chromatography, method be get the Oleum Curcumae sub-microemulsion injection add in mark be settled to after the normal concentration as need testing solution with dehydrated alcohol, sample introduction 1 μ l, chromatographic condition: 25m * 0.22mm, the PEG-20M fused-silica capillary column, flame ionization ditector, 210 ℃ of detector temperatures, 210 ℃ of injector temperatures, 163 ℃ of column temperatures, with nitrogen is carrier gas, and above-mentioned chromatographic condition can be with two kinds of main component good separation, accurately quantitatively.
Zedoary turmeric oil emulsion breast particle size determination method of the present invention is got this product 0.1ml, adds purified water (being 0.22 μ ml membrane filtration with the aperture in advance) and is diluted to 5000 times, and mixing as test liquid, adopts dynamic laser light scattering grain instrument mensuration after measured.
Oleum Curcumae submicron emulsion, the external release dynamic test of fat milk:
Get the Oleum Curcumae submicron emulsion 1ml of the present invention's preparation, its prescription is Oleum Curcumae 2g, lecithin 1.2g, water for injection 100ml; Get fat emulsion of oil of zedoary turmeric 1ml, its prescription is Oleum Curcumae 2g, soybean oil 10g, lecithin 1.2g, water for injection 90ml; Two kinds of emulsions are put into 50ml respectively discharge cup and stir, release medium is 10% alcoholic acid DDW, and each discharges in the cup and is equipped with 6 bag filters that contain the same release medium of 1ml respectively, and pre-balance 2 hours.Respectively at 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes, 60 minutes taking-up bag filters, measure curcumenol content, content assaying method is undertaken by method provided by the invention.Measure release medium Chinese medicine total concentration (comprising emulsion droplet Chinese medicine concentration) simultaneously and calculate release percentage rate on each time point, the results are shown in Table 1.
Table 1. Oleum Curcumae submicron emulsion, fat milk release percentage comparisons (%)
The result shows that the Oleum Curcumae submicron emulsion discharges medicine than fat milk when beginning fast, the drug level height, and prompting may comparatively fast reach blood drug level, then, slows down the medicine speed of dispelling misgivings, and keeps finite concentration, more helps the effect of antiviral pharmacology.
Oleum Curcumae submicron emulsion, fat milk stability test:
Oleum Curcumae submicron emulsion, fat milk are placed in the 2--10 ℃ of refrigerator, placed 1 year, observe outward appearance and measure quality control standard such as drug content,, therefore need to investigate peroxide value, free fatty, the results are shown in Table 2-3. because curcuma zedoary oil fat contains soybean oil
The assay method of peroxide, free fatty is as follows:
The peroxide value precision is measured this product 4ml, adds glacial acetic acid-chloroformic solution (3: 2) 30ml, and slowly jolting makes dissolving, adding saturated solution of potassium iodide (gets potassium iodide 200g, adds the cold water 100ml that newly boiled, the dissolving mixing, leave standstill, get the supernatant, in hermetic container, keep in Dark Place.) 0.5ml and starch indicator solution 0.5ml, jolting 1 minute adds water 30ml, and firmly jolting disappears to blue with sodium thiosulfate volumetric solution (0.01mol/L) titration, and titration results is proofreaied and correct with blank assay.The milliliter number of test sample consumption sodium thiosulfate volumetric solution (0.01mol/L) must not be greater than 0.2ml.
Oleic acid 5.649g is got in the preparation of free fatty reference substance solution, accurate claims surely, puts in the 200ml measuring bottle, adds normal heptane and is diluted to scale, shakes up, face with before, precision is measured 30ml, puts in the 200ml measuring bottle, adds normal heptane and is diluted to scale, shakes up.
The algoscopy precision is measured this product and each 1ml of reference substance solution, put respectively in the 20ml tool plug test tube, add isopropyl alcohol-normal heptane-0.5mol/L sulfuric acid solution (40: 10: 1) 5.0ml, jolting 1 minute was placed 10 minutes, need testing solution pipe precision adds normal heptane and each 3ml of water, contrast solution pipe precision adds normal heptane 2ml and water 4ml, and close plug spins upside down 10 times, left standstill at least 15 minutes, make layering, precision is measured upper strata liquid 3ml respectively, puts in the 10ml centrifuge tube, add Buddhist nun rowland indicator solution and (get Buddhist nun rowland 0.04g, add water 200ml, make dissolving after, add normal heptane 100ml, jolting, discard the upper strata normal heptane, repeatable operation 4 times is taken off a layer aqueous solution 20ml, add dehydrated alcohol 180ml, shake up.This liquid is put in the brown bottle, and room temperature can be deposited one month) 1ml, under logical condition of nitrogen gas, show lavender with sodium hydroxide volumetric solution (0.01mol/L) titration to solution.The milliliter number of need testing solution consumption sodium hydroxide volumetric solution (0.01mol/L) must not consume the milliliter number of sodium hydroxide volumetric solution (0.01mol/L) greater than reference substance solution.
Table 2. Oleum Curcumae submicron emulsion study on the stability result
Table 3. curcuma zedoary oil fat study on the stability result
By table 2-3 result as seen, the Oleum Curcumae submicron emulsion places in the 2--10 ℃ of refrigerator, place after 1 year, and every quality control index, all up to specification.The peroxide of curcuma zedoary oil fat, free fatty placement all change after 6 months and then influence content.
Curcuma zedoary oil submicro emulsion irritation test of the present invention, the method that No. 200410100424.1, the employing Chinese patent:
1, hank 24 of year healthy rabbit, the male and female dual-purpose, body weight 2.0～2.5kg, random packet is given normal saline for first group, and second group is Oleum Curcumae injection, and the 3rd group is the Oleum Curcumae sub-microemulsion injection.Through the auricular vein administration, 20ml/, 1ml/ branch constant speed pushes, and puts to death animal in two hours behind the medicine, gets the injection site, and 10% Fu Erduolin is liquid-solid fixed, paraffin embedding, and H.E. dyeing, simple microscope is observed the injection site blood vessel down, and blood capillary is to the reaction of medicine
2, hank 24 of year rabbit, the male and female dual-purpose, body weight 2.0～2.5kg, random packet, first group is normal saline, and second group is Oleum Curcumae injection, and the 3rd group is the Oleum Curcumae sub-microemulsion injection.Be administered once through auricular vein every day, 20ml/ only, 1ml/ branch constant speed pushes, one week of successive administration, 2 hours execution animals behind the 7th day medicine, get the injection site, 10% formalin solution is fixed, paraffin embedding, H.E. dyeing, simple microscope is observed the injection site blood vessel, and blood capillary is to the reaction of medicine.
Single administration is to vascular stimulation effect table 1.
2 hours stimulations behind the table 1 Oleum Curcumae sub-microemulsion injection medicine to blood vessel
| Group | Animal number | Adhesion of ear vein neutrophil and infiltration | The blood capillary neutrophil is adhered and is invaded profit | The edema of stroma | The stroma neutrophil soaks into |
| The I normal saline | ????1 ????2 ????3 ????4 ????5 ????6 ????7 ????8 | ????- ????- ????- ????- ????- ????- ????- ????- | ????- ????- ????- ????- ????- ????- ????- ????- | ????- ????- ????- ????- ????- ????- ????- ????± | ????- ????- ????- ????- ????- ????- ????± ?????????± |
| The II Rhizoma Curcumae | ????1 ????2 ????3 | ????- ????- ????+ | ????- ????- ????+ | ????- ????- ????± | ????- ????- ????+ |
| Fat injection | ??4 ??5 ??6 ??7 ??8 | ????± ???????++ ????± ?????????- ?????- | ± ++ + - - | - + ± - - | ????+ ????++ ????± ????????- ????- |
| III property of submicron emulsion parenteral solution | ??1 ??2 ??3 ??4 ??5 ??6 ??7 ??8 | ????- ????- ????- ????- ????- ????- ????- ????- | - - ± - - - - - | - - ± - ± - - - | ????- ????- ????++ ????- ????- ????- ????± ????????- |
-cloudy, ± change of utmost point hypopathia ,+the hypopathia change, ++ the severe pathological changes
By table 1 as seen, there is 1 routine neutrophil to adhere to and soak in Oleum Curcumae sub-microemulsion injection 8 examples, and has 4 routine neutrophils to adhere to and soak in Oleum Curcumae injection 8 examples to blood vessel wall to blood vessel wall.Both all have in various degree between the matter edema.
Successive administration is to vascular stimulation effect table 2.
Table 2 Oleum Curcumae sub-microemulsion injection successive administration is to the vascular stimulation effect
| Group | Animal number | Ear vein | Blood capillary | |||||
| Mixed thrombus | Hyaline thrombus | Endothelium swelling | V wall inflammation | Scorching around the V | Congested | Perivasculitis | ||
| I organizes normal saline | ??1 ??2 ??3 ??4 ??5 ??6 ??7 ??8 | There is not " " " " " " " | There is not " " " " " " " | ??- ??″ ????″ ????″ ????″ ????″ ????″ ????″ | ??- ??″ ????″ ????″ ????″ ????″ ????″ ????″ | ??- ??″ ????″ ????″ ????″ ????″ ????″ ????″ | ?± ??″ ??″ ??″ ??- ?± ??″ ??″ | ????- ????″ ????????″ ????????″ ????????″ ????????″ ????????″ ????????″ |
| II organizes Oleum Curcumae injection | ??1 ??2 ??3 ??4 ??5 ??6 ??7 ??8 | Nothing has the beginning machine not have to be had | There is not " " " " " " " | ??- ??+ ??+ ??+ ??- ??+ ??+ ??+ | ??- ??± ?????± ?????+ ???- ??± ?????± ?????+ | ??- ??± ????± ????+ ??- ??+ ??± ????+ | ?+ ?″ ??″ ??″ ??″ ??″ ??″ ??″ | ????- ????+ ????+ ????+ ????- ????+ ????+ ????+ |
| III group property of submicron emulsion parenteral solution | ??1 ??2 ??3 ??4 ??5 ??6 ??7 ??8 | Do not have | Do not have " " and have or not " " " | ??- ??- ??-? ??± ????- ??- ??- ??- | ??- ??- ??- ??- ??- ??- ??- ??- | ??- ??- ??- ??- ??- ??- ??- ??- | ?+ ?″ ??″ ??″ ??″ ??″ ??″ ??″ | ????- ????- ????- ????± ????????- ????- ????- ????- |
-cloudy, ± change of utmost point hypopathia ,+slight pathological changes
As seen from Table 2, there are 6 examples all to have mixed thrombus in Oleum Curcumae injection 8 examples.Has only the slight hyaline thrombus of 1 example in Oleum Curcumae sub-microemulsion injection 8 examples.The two all has inflammatory reaction around in various degree venous endothelial swelling, the capillary tube, but the Oleum Curcumae sub-microemulsion injection significantly is lighter than injection.
Advantageous effect of the present invention is as follows:
Curcuma zedoary oil submicro emulsion is compared with present Oleum Curcumae injection, does not contain tween 80, has reduced untoward reaction such as the haemolysis that causes thus, allergy.Compare with the fat emulsion of oil of zedoary turmeric that contains soybean oil, have littler breast grain particle diameter, reduced generation heating, shiver with cold, cardiopalmus, rapid breathing, the headache side effect that may be brought by soybean oil, long-term input causes untoward reaction such as Glutamate pyruvate transaminase rises easily.Do not contain free fatty and antioxidant, avoid the stability problem that causes by becoming sour.Simultaneously, curcuma zedoary oil submicro emulsion removes possesses the fat emulsion of oil of zedoary turmeric target phasic property that contains soybean oil, and outside the long-acting, its oil-in-water nanometer grain has littler particle diameter, and the breast grain is made up of medicine fully, faster release medicine, performance drug effect.
Oleum Curcumae is under natural lecithin effect, and Oleum Curcumae oil phase and water form nano-emulsion through the equal machine emulsifying of high pressure breast.The Oleum Curcumae effective ingredient is in the oil phase of oil-in-water lipoid microsphere fully, forms nano_scale particle, is easy to discharge medicine, performance antiviral and antitumaous effect, because its targeting, to anticancer more meaningful.Because aqueous phase does not contain Zedoary turmeric oil, will alleviate greatly blood vessel irritation, effectively reduce owing to drug-induced phlebitis, possibility hypersensitive strengthens patient's compliance.
The specific embodiment
Embodiment 1
Fat emulsion of oil of zedoary turmeric of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=2: 1.2: 2.5: 90;
By above-mentioned weight ratio weighing Oleum Curcumae 2g; Get 1.2g refine yolk lecithin (German lipoid company), add 90g water for injection, 2.5g glycerol is heated to 70 ℃, and with 15000rpm, homogenizing disperseed 5 minutes, was cooled to room temperature, was water in high-speed homogenization machine (Jintan, Zhejiang instrument plant); Add above-mentioned load weighted Oleum Curcumae 2g to aqueous phase, high-speed homogenization 5 minutes forms colostrum, colostrum is joined the high pressure breast all in the machine (Italian ATS company), logical N
2Protection, initial pressure is 20～30MPa, circulates 2 minutes, rises to 80～100Mpa then, circulates 6 times, emits homogenized milk.In hundred grades of cleaning shops, adopt microporous filter membrane equipment, cross 0.45 μ m filter membrane, packing.Adopt pressure sterilizing to sterilize, the pressure sterilizing condition is 121 ℃, 15 minutes.Through gas Chromatographic Determination, contain curcumenol 3.6mg/ml, particle diameter 180nm with the stimulating milk secretion grain greater than 98%.
Embodiment 2
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=1: 0.5: 0.5: 70;
Preparation technology is with embodiment 1.Make Emulsion through gas Chromatographic Determination, contain curcumenol 1.8mg/ml, particle diameter 300nm with the stimulating milk secretion grain greater than 95%.
Embodiment 3
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=5: 3: 3: 90;
The method of embodiment 1 described sterilization adopts the method for microwave sterilizating, after promptly fat emulsion of oil of zedoary turmeric filters, fills N
2, fill in the 2450MHZ frequency, under the power 1KW, was sterilized 30 seconds, and other is with embodiment 1.Make Emulsion through gas Chromatographic Determination, contain curcumenol 8.8mg/ml, particle diameter 300nm with the stimulating milk secretion grain greater than 98%.
Embodiment 4
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=2: 1.5: 2.5: 90;
Preparation technology makes Emulsion through gas Chromatographic Determination with embodiment 1, contains curcumenol 3.2mg/ml, particle diameter 190nm with the stimulating milk secretion grain greater than 98%.
Embodiment 5
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=1: 1: 2: 85;
Preparation technology is with embodiment 1.Contain curcumenol 2.1mg/ml, particle diameter 300nm with the stimulating milk secretion grain greater than 98%.
Embodiment 6
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=1: 3: 3: 90; Preparation technology is with embodiment 1.Contain curcumenol 1.9mg/ml, particle diameter 300nm with the stimulating milk secretion grain greater than 96%.
Embodiment 7
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=5: 0.5: 0.5: 70;
Preparation technology is with embodiment 1.Contain curcumenol 9.8mg/ml, particle diameter 300nm with the stimulating milk secretion grain greater than 90%.
Embodiment 8
Curcuma zedoary oil submicro emulsion of the present invention is made of by weight following raw material:
Oleum Curcumae: soybean lecithin: glycerol: water for injection=2: 1.2: 2.5: 90;
Preparation technology is with embodiment 1.Contain curcumenol 3.8mg/ml, particle diameter 300nm with the stimulating milk secretion grain greater than 90%.
Embodiment 9
Press embodiment 1, filter through 0.45 μ m and obtain curcuma zedoary oil submicro emulsion of the present invention, packing after 0.22 μ m filter membrane degerming contains curcumenol 3.4mg/ml, accounts for more than 99% below the particle diameter 170nm.
Embodiment 10
Press embodiment 1, membrane filtration obtains curcuma zedoary oil submicro emulsion packing of the present invention through hole, 0.45 μ m emblem, uses 2450MHz, power 1KW, and microwave sterilizating 30 seconds, that is, other is with embodiment 1.Gas Chromatographic Determination contains curcumenol 4.0mg/ml, and particle diameter accounts for more than 99% less than 200nm.
Embodiment 11
Pressing the egg yolk lecithin described in the embodiment 1 to 9 can substitute with soybean lecithin, has prepared Oleum Curcumae curcuma zedoary oil submicro emulsion of the present invention.With the egg yolk lecithin among the embodiment 1 with the alternative curcuma zedoary oil submicro emulsion that makes of soybean lecithin after measured, the white Emulsion for homogeneous contains curcumenol 3.9mg/ml, and the breast footpath accounts for 95% less than 300nm.
Embodiment 12
Other changed the high-speed homogenization machine into supersonic oscillations 5 minutes with embodiment 1.
Embodiment 13
Other, is added to colostrum in the high pressure homogenizer behind the formation colostrum with embodiment 1, and just section pressure adopts 20～30Mpa, and two-stage nitration adopts 40～100Mpa, circulates 3～6 times, and blowing behind the homogenizing adopts 0.45 μ m filtering with microporous membrane.Fill N
2Fill, pressure sterilizing, 115 ℃, 30 minutes, promptly.
Claims (7)
1, a kind of curcuma zedoary oil submicro emulsion is characterized in that being made up of by weight following raw material:
Oleum Curcumae: lecithin: glycerol: water for injection=1～5: 0.5～3: 0.5～3: 70～90.
2,, it is characterized in that forming by weight by following raw material by the described curcuma zedoary oil submicro emulsion of claim 1:
Oleum Curcumae: lecithin: glycerol: water for injection=1～2: 1～1.5: 2～2.5: 85～90.
3, by claim 1 or 2 described curcuma zedoary oil submicro emulsions, it is characterized in that described lecithin is egg yolk lecithin or soybean lecithin.
4, the preparation method of a kind of claim 1 or 2 described Oleum Curcumae curcuma zedoary oil submicro emulsion of the present invention is characterized in that it comprises following processing step:
By the refining lecithin of above-mentioned weight ratio weighing, add in the water for injection, add glycerol again, be heated to 50～70 ℃, homogenizing disperseed 2～5 minutes in the high-speed homogenization machine, was cooled to room temperature, was water; Add Oleum Curcumae to aqueous phase, high-speed homogenization 2～5 minutes forms colostrum; Colostrum is joined in the equal machine of high pressure breast, under 20～100Mpa pressure, logical N
2Protection through 3-6 circulation, forms the Emulsion of homogeneous; emit homogenized milk, adopt microporous filter membrane equipment, cross 0.45 μ m filter membrane; after 0.22 μ m degerming filter membrane sterilization back packing, perhaps adopt pressure sterilizing to sterilize after the packing, the pressure sterilizing condition is 121 ℃, 15 minutes or 115 ℃, 30 minutes.
5. by the preparation method of the described curcuma zedoary oil submicro emulsion of claim 4, it is characterized in that: the method for sterilization adopts the filtration sterilization mode, hundred grades of cleaning shops, promptly after adopting 0.45 μ m filtering with microporous membrane, adopts 0.22 μ m filtering with microporous membrane again, fills N
2, fill.
6. by the preparation method of the described curcuma zedoary oil submicro emulsion of claim 4, it is characterized in that: the method for sterilization adopts the method for microwave sterilizating, after promptly zedoary turmeric oil emulsion filters, fills N
2, fill in the 2450MHZ frequency, under the power 1KW, was sterilized 30 seconds, promptly.
7. by the preparation method of the described curcuma zedoary oil submicro emulsion of claim 4, it is characterized in that: the method for preparing colostrum can adopt the supersonic oscillations method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100463682A CN100502835C (en) | 2005-04-30 | 2005-04-30 | Zedoary turmeric oil submicron emulsion and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100463682A CN100502835C (en) | 2005-04-30 | 2005-04-30 | Zedoary turmeric oil submicron emulsion and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1686326A true CN1686326A (en) | 2005-10-26 |
| CN100502835C CN100502835C (en) | 2009-06-24 |
Family
ID=35304368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100463682A Expired - Fee Related CN100502835C (en) | 2005-04-30 | 2005-04-30 | Zedoary turmeric oil submicron emulsion and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100502835C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101006997B (en) * | 2006-01-26 | 2011-07-20 | 董英杰 | Compound taxol and its derivative docetaxel fat emulsion and preparation method |
| CN101554369B (en) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof |
| CN105831689A (en) * | 2016-03-29 | 2016-08-10 | 杭州娃哈哈科技有限公司 | Method for preparing single lemon microemulsion essence |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1430981A (en) * | 2002-12-04 | 2003-07-23 | 张忠义 | Zedoary oil product of virus safe medicine and its preparing method |
-
2005
- 2005-04-30 CN CNB2005100463682A patent/CN100502835C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101006997B (en) * | 2006-01-26 | 2011-07-20 | 董英杰 | Compound taxol and its derivative docetaxel fat emulsion and preparation method |
| CN101554369B (en) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof |
| CN105831689A (en) * | 2016-03-29 | 2016-08-10 | 杭州娃哈哈科技有限公司 | Method for preparing single lemon microemulsion essence |
| CN105831689B (en) * | 2016-03-29 | 2018-08-03 | 杭州娃哈哈科技有限公司 | A kind of preparation method of single times of lemon micro emulsion essence |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100502835C (en) | 2009-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110498935B (en) | High internal phase emulsion with quercetin stabilized by soy protein isolate-pectin compound and preparation method thereof | |
| CN109996551A (en) | The method of selective extraction cannboid from plant source | |
| CN106579327A (en) | High internal phase gel-like zein Pickering emulsion and preparation method thereof | |
| TWI428144B (en) | O / W / O latex containing xylan compounds and compositions containing them | |
| CN1153474A (en) | Stable oil-in-water emulsions incorporating taxine (taxol) and method of making same | |
| RU2716218C2 (en) | Composition for injection based on a fat emulsion of cabazitaxel, a method for its preparation and application | |
| CN107308111B (en) | Olive oil-containing medium/long-chain fat emulsion injection and preparation method thereof | |
| CN1307903A (en) | Vaccine wine oil adjuvant | |
| CN1872072A (en) | Nano emulsion injection of alprostadil and preparation method | |
| CN111011858A (en) | Mixed oil emulsion for improving bioavailability of fat-soluble active substances and preparation method thereof | |
| CN102143764A (en) | Nanocrystal nano-emulsion | |
| CN106236709A (en) | A kind of gleptoferron nano-emulsion and preparation method thereof | |
| CN102448441A (en) | Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof | |
| Yang et al. | Effects of preheating and storage temperatures on aroma profile and physical properties of citrus-oil emulsions | |
| ES2922815T3 (en) | Preparation of an oil-in-water emulsion for pharmaceutical formulations stabilized with polymers | |
| Deng et al. | Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion | |
| CN1686326A (en) | zedoary turmeric oil submicron emulsion and preparation method thereof | |
| CN102319214A (en) | Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof | |
| CN1676125A (en) | Nano-level emulsion containing taxine or hard-soluble medicine | |
| CN113876658A (en) | Oil-in-water emulsion composition and method for producing the same | |
| Satapathy et al. | Development of mustard oil-and groundnut oil-based span 40 organogels as matrices for controlled drug delivery | |
| CN1965805A (en) | Coenzyme Q10Submicron emulsion injection and preparation method thereof | |
| CN100515389C (en) | Medicinal emulsion adapted for difficultly soluble medicine and method for preparing the same | |
| CN116539550A (en) | Construction and application of antarctic krill oil self-emulsifying system | |
| CN1788723A (en) | Liposome microsphere injection liquid containing demethylate disodium cantharidinate and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090624 Termination date: 20120430 |